PharmChem, Inc.
PCHM
$3.82
-$0.1112-2.83%
OTC PK
| 09/30/2003 | 06/30/2003 | ||||
|---|---|---|---|---|---|
| Revenue | -2.42% | 12.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.42% | 12.30% | |||
| Cost of Revenue | -4.82% | 8.20% | |||
| Gross Profit | 6.05% | 29.67% | |||
| SG&A Expenses | 0.00% | 10.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.55% | 8.75% | |||
| Operating Income | 22.89% | 29.42% | |||
| Income Before Tax | 144.86% | 24.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 144.86% | 24.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 144.86% | 24.28% | |||
| EBIT | 22.89% | 29.42% | |||
| EBITDA | 42.24% | 514.29% | |||
| EPS Basic | 144.83% | 24.28% | |||
| Normalized Basic EPS | 25.13% | 24.27% | |||
| EPS Diluted | 142.19% | 27.08% | |||
| Normalized Diluted EPS | 25.97% | 24.27% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.20% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||